Certara, a provider of model-informed drug development, regulatory science, real-world evidence and market access services, has announced four senior executive appointments in its Simcyp division
Certara, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the launch of version 19.1 of its flagship scientific informatics platform D360.
D360 v19.1 expands the platform’s capabilities for biologists and biologics scientists, deepens support for small molecule chemistry, and provides workflow enhancements based on community feedback. This latest version of D360 takes its name from its calendar release date; this is the first new release in 2019.
Certara, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the launch of version 18 of its Simcyp Population-based Simulator
Certara has announced that Craig Rayner, PharmD, MBA, senior vice president, integrated drug development with Certara Strategic Consulting, has been awarded the 2018 Distinguished Alumni Award for the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University.
Certara has announced that the US Food and Drug Administration (FDA) has renewed, and in many cases increased, its number of Certara software licenses for reviewing new drug and biologics applications
Certara has announced that it has Pirana, a product for connecting and organising pharmacometric modelling results as well as providing interfaces to a range of software tools used in pharmacometrics modelling
Certara, a provider of model-informed drug development, has announced the launch of D360 v10.5, the first in a series of releases focused on delivering biologic-relevant tools together with D360’s world-class data access capabilities
Certara has reported that 95 per cent of novel new drug approvals by the US Food and Drug Administration (FDA) in the first half of 2018 was supported by Certara software or services
Certara, a provider of in model-informed drug development, regulatory science, market access and real-world evidence services, has announced the launch of Analytica Laser’s Market Access Radar, a three times weekly market access intelligence briefing.
This market access data is also available via an easily searchable web portal.
Certara, a provider of model-informed drug development and regulatory science, has announced that it has acquired Analytica Laser
Digital transformation continues to impact our lives in ways we previously couldn’t have imagined, comments Trish Meek, director of marketing at Thermo Fisher Scientific.
Weather prediction seems simple nowadays. You just have to summon Siri and ask it if you’ll need an umbrella or a sunhat.
In March it was announced that a new exascale system was on the horizon, with the news that Aurora – originally scheduled for 2018 – was going to be the first exascale system in the US, launching in 2021.
The storage market is in a unique position, in that there is demand from both the traditional HPC and enterprise storage markets, such as media and entertainment, alongside new growing markets for AI and machine learning.
